This 2019 study demonstrated that mesenchymal stem cell exosomes can alleviate temporomandibular joint (TMJ) osteoarthritis by reducing inflammation and restoring matrix homeostasis — the healthy balance of joint tissue components.

For patients suffering from chronic jaw pain and TMJ dysfunction, this research supports exosome therapy as a promising treatment option.

This is a research reference from our clinical library. Approved by the Chambers Clinic Team — last reviewed May 28, 2026.